Bank Of New York Mellon Corp Dario Health Corp. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.79 - $6.22 $105,240 - $172,716	27,768 New	27,768 $114 Million
Q4 2022 Feb 14, 2023	BUY	$3.53 - $5.49 $98,021 - $152,446	27,768 New	27,768 $118,000
Q3 2022 Nov 14, 2022	BUY	$3.74 - $7.09 $104,450 - $198,009	27,928 New	27,928 $129,000
Q2 2022 Aug 15, 2022	SELL	$4.33 - $7.45 $187,597 - $322,771	-43,325 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$5.84 - $13.61 $12,363 - $28,812	-2,117 Reduced 4.66%	43,325 $253,000
Q4 2021 Feb 11, 2022	BUY	$12.52 - $19.02 $4,957 - $7,531	396 Added 0.88%	45,442 $589,000
Q3 2021 Nov 12, 2021	BUY	$10.47 - $20.87 $45,136 - $89,970	4,311 Added 10.58%	45,046 $615,000
Q2 2021 Aug 11, 2021	BUY	$13.9 - $22.58 $566,216 - $919,796	40,735 New	40,735 $870,000

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $16.3M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.